PET imaging

February 26, 2018February 26, 2018

New Diagnostic Tool for Metastatic Prostate Cancer Advances Following License Agreement

News

The development of CTT1057, a new product for the diagnosis of metastatic prostate cancer, received a boost with the worldwide license agreement between Novartis-held company Advanced Accelerator Applications (AAA) and ... Read more

October 11, 2016

PET, MRI Combination Helps Map Prostate Cancer Relapses

News

Combining two imaging techniques has allowed researchers to study the patterns of prostate cancer recurrence following radical prostatectomy (removal of the prostate). Titled “Contemporary Mapping Of Post-Prostatectomy Prostate Cancer Relapse With C-11 Choline ... Read more

June 2, 2016June 6, 2016

FDA Approves Novel Diagnostic to Detect Recurrent Prostate Cancer

News

Blue Earth Diagnostics’ Axumin, a radioactive diagnostic agent for injection, was approved May 27 the U.S. Food and Drug Administration (U.S. FDA) for positron emission tomography (PET) imaging in men ... Read more